CGRNX
Price
$32.15
Change
-$0.91 (-2.75%)
Updated
Feb 3 closing price
Net Assets
831.39M
RMEBX
Price
$60.49
Change
-$1.74 (-2.80%)
Updated
Feb 3 closing price
Net Assets
111.52B
Interact to see
Advertisement

CGRNX vs RMEBX

Header iconCGRNX vs RMEBX Comparison
Open Charts CGRNX vs RMEBXBanner chart's image
Invesco Comstock Select R
Price$32.15
Change-$0.91 (-2.75%)
VolumeN/A
Net Assets831.39M
American Funds American Mutual R2E
Price$60.49
Change-$1.74 (-2.80%)
VolumeN/A
Net Assets111.52B
CGRNX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
CGRNX vs. RMEBX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRNX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 112B vs. CGRNX (831M). CGRNX (1.11) and RMEBX (1.08) have matching dividends . CGRNX was incepted earlier than RMEBX: CGRNX (25 years) vs RMEBX (11 years). CGRNX (1.18) is less costly to investors than RMEBX (1.07). CGRNX is a more actively managed with annual turnover of: 70.00 vs. RMEBX (30.00). CGRNX has a lower initial minimum investment than RMEBX: CGRNX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 7.30 vs. CGRNX (5.22). RMEBX return over 5 years is better than : 43.15 vs. CGRNX (20.07).
CGRNXRMEBXCGRNX / RMEBX
Total Expense Ratio1.181.07110%
Annual Report Gross Expense Ratio1.181.07110%
Fund Existence25 years11 years-
Gain YTD3.6762.231165%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets831M112B1%
Annual Yield % from dividends1.111.08102%
Returns for 1 year5.227.3071%
Returns for 3 years7.1528.2125%
Returns for 5 years20.0743.1547%
Returns for 10 years34.47103.9533%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMRA2.040.06
+3.03%
Neumora Therapeutics
AMRC31.440.87
+2.85%
Ameresco
KOYNU10.17N/A
N/A
CSLM Digital Asset Acquisition Corp III
ORIS1.25-0.08
-6.02%
Oriental Rise Holdings Ltd
OWL12.11-1.31
-9.76%
Blue Owl Capital